stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Exo Imaging, Inc.

United States · Privately owned

Exo makes a handheld ultrasound device and the software that helps doctors use it.

Exo makes a pocket-sized ultrasound scanner called the Iris and the software that runs it. Doctors and nurses can pick it up, press it against a patient's body, and see inside in real time, the way you'd use a camera rather than wheel in a big cart-based machine. Ultrasound is one of medicine's most useful tools because it's safe, painless, and shows soft tissue and moving organs well, but for decades it lived mostly in radiology departments and specialist offices because the machines were expensive and bulky. Exo's pitch is to put that power in more hands, at the bedside, in the emergency room, in clinics, and in places that never had a scanner at all.

The company sells the hardware and pairs it with cloud-based workflow software. That software matters more than it sounds: it handles image storage, lets doctors review scans and share them with colleagues, and uses artificial intelligence to help get a cleaner image or point out what's worth a closer look. In other words, Exo isn't just selling a gadget, it's selling a system that turns a handheld probe into something a busy clinician can actually fold into their day. Customers include hospitals, health systems, and clinicians who want imaging without sending a patient down the hall or across town. The hard part is that Exo is swimming with giants. General Electric and Philips have dominated ultrasound for years, and a wave of newer handheld players, including Butterfly Network, has crowded into the same pocket. Exo's bet is that its chip-based design and its software can make its scanner cheaper to build and easier to use than the cart-based competition, while giving clearer images than the cheapest handhelds. Getting a medical device cleared by regulators and then convincing hospitals to change how they work is slow, expensive work, and Exo has raised a lot of venture money to fund that push.


Exo was founded in 2015 and is based in Santa Clara, California, in the heart of Silicon Valley's hardware world. It remains a private, venture-backed company, so its shares don't trade on an exchange and its finances aren't public the way a listed company's are. That means its real test is not a stock price but whether health systems adopt the Iris at scale and whether the company can eventually turn that adoption into a profitable business. For now, it's a bet that the future of medical imaging looks less like a room-sized machine and more like a tool a doctor can carry.

Saved answer · last researched 16 Nov 2026